Loading…

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast

Many studies have investigated the relationship between the E‐cadherin/catenin axis and breast cancer biology and yet, unlike the studies in other tumour systems, which have shown a relationship between down‐regulation and poor survival, no clear association has emerged in breast. Since accumulating...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pathology 2001-04, Vol.193 (4), p.433-441
Main Authors: Gillett, C. E., Miles, D. W., Ryder, K., Skilton, D., Liebman, R. D., Springall, R. J., Barnes, D. M., Hanby, A. M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Many studies have investigated the relationship between the E‐cadherin/catenin axis and breast cancer biology and yet, unlike the studies in other tumour systems, which have shown a relationship between down‐regulation and poor survival, no clear association has emerged in breast. Since accumulating evidence suggests that ductal carcinoma of no special type (NST) represents a diverse group of biologies, this study has focused on grade III ductal carcinoma, in order to reduce the heterogeneity of the study population. A total of 470 breast tumours were studied. Consecutive sections were labelled with antibodies which recognize E‐cadherin and the arm proteins with which it interacts: α‐, β‐, and γ‐catenin. Membrane‐bound and cytoplasmic E‐cadherin and membrane‐bound α‐catenin expression were associated with a positive oestrogen receptor (ER) status, γ‐catenin with a negative ER status, and, surprisingly, all three with poor survival. Taken together, these findings suggest that a conserved E‐cadherin/catenin axis may play a part in determining adverse outcome in grade III breast carcinoma. Copyright © 2001 John Wiley & Sons, Ltd.
ISSN:0022-3417
1096-9896
DOI:10.1002/path.831